Senetek PLC to Present at the Sachs-Bloomberg Biotech in Europe Investor Forum in Munich to Be Held November 5-6, 2002
Friday October 11, 8:01 am ET
NAPA, Calif., Oct. 11 /PRNewswire-FirstCall/ -- Senetek PLC (Nasdaq: SNTK - News), www.senetekplc.com , a biopharmaceutical company focused on licensing, co-marketing and developing products in the key skincare/dermatological and sexual dysfunction categories worldwide, has been invited to present at the Sachs-Bloomberg Biotech in Europe Investor Forum held in Munich on Tuesday & Wednesday, November 5-6, 2002. The presentation, scheduled for Tuesday, November 5, 2002 at 11:00am, will focus on the Company's current business and proprietary technologies and its future growth prospects.
In partnership with the Financial Times Deutschland, and organized by Sachs Associates in association with Bloomberg L.P., the event is sponsored by major venture capital funds such as DVC Deutsche Venture Capital and Global Life Science Ventures, and world renowned companies such as Novartis Pharma AG as well as the SWX Swiss Exchange.
The forum will be held at the Hilton Muenchen Park. On-site registration begins at 8:00am on Tuesday, November 5, 2002. The Hilton Muenchen Park is located at Am Tucherpark 7, Munich, Germany. Further information is available at www.sachsforum.com .
Safe Harbor Statement
This news release may contain statements that may be considered "forward- looking statements" under the Federal securities laws, including statements concerning the revenue and licensing income the Company may receive in the future under licenses of the Company's products, and the additional licensing agreements the Company may enter into during 2002. No forward-looking statement the Company makes is a guarantee of future performance or events. Actual results or events may differ materially from those in the forward- looking statements as a result of various factors, including the risks and uncertainties described in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2001 and Quarterly Report on Form 10-Q for the three months ended June 30, 2002, filed with the Securities and Exchange Commission.
Make Your Opinion Count - Click Here
--------------------------------------------------------------------------------
Source: Senetek PLC |
